Investors › Bristol-Myers Squibb
Bristol-Myers Squibb logo

Bristol-Myers Squibb

Venture capital · Trenton, New Jersey, United States · bms.com ↗

Bristol Myers Squibb (BMS) is a prominent global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases. Established in 1989 through the merger of Bristol-Myers Company and Squibb Corporation, BMS is headquartered in Princeton, New Jersey. The company is publicly traded on the New York Stock Exchange under the ticker symbol BMY and is part of the S&P 100 and S&P 500 indices. BMS specializes in the full lifecycle of pharmaceutical product development, including drug discovery, clinical development, manufacturing, and commercializa

LinkedIn ↗+1 609-252-4621

Investing activity

Bristol-Myers Squibb is listed on AI Lounge as a venture capital investor based in Trenton, New Jersey, United States. The deals desk records Series A and later AI rounds and seeds over $10M, so smaller checks may not show here yet.

Deals

0
AI rounds and acquisitions Bristol-Myers Squibb took part in, newest first.
No deals yet.

Frequently asked questions about Bristol-Myers Squibb

Where is Bristol-Myers Squibb based?

Bristol-Myers Squibb is based in Trenton, New Jersey, United States.

How can founders reach Bristol-Myers Squibb?

Founders on AI Lounge can see Bristol-Myers Squibb's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Bristol-Myers Squibb to their Investor Pipeline to track the conversation.

AI Lounge Pro members see the full Investors ranking, who is writing checks, how many, how much, and their contact details, plus CSV exports. Plans start at $19/mo.
See plans →Log in